Skip to main content
. Author manuscript; available in PMC: 2011 Jan 28.
Published in final edited form as: AIDS. 2010 Jan 28;24(3):353–363. doi: 10.1097/QAD.0b013e3283333666

Figure 1.

Figure 1

Percentage of participants who were taking ART in the DC and VS groups, through follow-up (panel A); changes in limb fat by DEXA from baseline through follow-up (percent relative to baseline, panel B; absolute change from baseline, panel C) and changes in visceral adipose tissue by CT (panel D). Right-hand panels of B–D show estimated treatment differences with 95% confidence intervals for change from baseline to month 12, and through follow-up. Treatment differences, confidence intervals and p-values were estimated using regression models (at each visit) and longitudinal models (through month 36). All models included race, sex and their interaction as covariates.

Abbreviations: ART, antiretroviral therapy; CI, confidence interval; CT, computed tomography; DC, Drug Conservation (intermittent ART) group; DXA, dual x-ray absorptiometry; VAT, visceral adipose tissue; VS, Viral Suppression (continuous ART) group